Taken together, this study suggests that the MRI-based radiomics plus clinical risk factor model can be used for predicting Ki-67 and CK-19 expression in HCC using 10% LI and 5% LI as the positive thresholds for the two markers, respectively. The gene discussed is KRT19; the disease is hepatocellular carcinoma.